On March 28th, a sub-forum on the pharmaceutical and healthcare industry was held as part of the 2018 Guangzhou Annual Investment Conference, aiming to outline the latest progress and emerging opportunities in the industry.
Chen Mao, General Manager of GPHL, shows the enterprise's exhibition at the investment forum to the attendants. [Photo provided to Newsgd.com]
Organized by Guangzhou Pharmaceutical Holdings Limited (GPHL), a leading Guangzhou-based pharmaceutical group, the sub-forum attracted over 100 attendants from the government, enterprises and academia, and invited leading practitioners to share both their research outcomes and observations about today’s market.
Yu Jianshe, Vice Chairman of the CPPCC Guangzhou Committee, said Guangzhou has been dedicated to the development of IAB industries (chiefly: IT, AI and bio-tech), and that GPHL is one of the city’s a leading IAB enterprises. “We welcome enterprises and investors worldwide to settle in Guangzhou, and cooperate with our local players for substantial development,” said Yu.
Liu Changxiao, an academic from the Chinese Academy of Sciences, delivering a speech during the forum.[Photo provided to Newsgd.com]
Liu Changxiao, a leading scholar from the Chinese Academy of Sciences, delivered a speech during the forum, focusing on the social environment, health issues and investment under China’s recent policies. He said that the pharmaceutical and healthcare industries have become increasingly popular no matter whether considering domestic or overseas markets, and that they would account for over 15% of China’s GDP in the future.
Liu Changxiao said that medicine has primarily been developed with the aim of curing disease, but that now it should be more about healthcare. Maintaining good health is a growing priority among people of all ages. “The government and enterprises should support with policies, increased industry standards, investment and talent, and boost the development of the healthcare industry,” he said.
During the forum, a number of overseas representatives gave presentations pitching their busines and expressing willingness to cooperate with local enterprises.
Kalim Mir, Founder of XGenomes, giving a presentation at GPHL’s forum.
Kalim Mir, Founder of XGenomes, spoke on how his company has invented a DNA sequencing technology which could facilitate precision medicine with lower costs and higher efficiency. “I hope Chinese pharmaceutical companies could invest more in new technology around the world, so that we may further development,” he said.
In addition, GPHL also demonstrates its Wanglaoji’s TCM bar-code system during the investment conference. The system enables traditional Chinese medicine to be identified via DNA technology, and has gained a prestigious national science award.
Wanglaoji’s TCM bar-code system is displayed at the 2018 Guangzhou Annual Investment Conference.[PhotoNewsgd.com]
Chen Mao, General Manager of GPHL, said an enterprise could not develop without cooperation with its industrial counterparts. “In this sense (of mutual cooperation), the pharmaceutical and healthcare forum gathers international talent and resources to map out how best to boost industrial development,” said Chen.
Reported by Jasmine Yin
Edited by Wing Zhang, Simon Haywood
